There are multiple imaging modalities which can assess for cardiac amyloidosis. However, each modality has strengths and weaknesses. Participants will learn how each modality can be utilized most effectively for the benefit of patients.
- Cardiac Amyloidosis: Disease Overview, Prevalence, and Genetics
- Imaging in Cardiac Amyloidosis: Role of Echo/CMR in Cardiac Amyloidosis
- Cardiac MRI Positive: What Next? AL or TTR: Role of Nuclear Cardiac Imaging
- Multimodality Imaging in Cardiac Amyloidosis: Putting it Together: Case Illustrations
Speakers: Calvin Chin Woon Loong, MD; Amit Patel, MD; Sharmila Dorbala, MD; Karthikeyan Ananthasubramaniam, MD
Moderators: Marianna Fontana, MD
The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Society for Cardiovascular Magnetic Resonance (SCMR) designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Claiming CME
- Attend the sessions in full for which credit is sought
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
The planners and faculty for this activity did not have any relationships to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
Dr. Dorbala receives research research grants from Pfizer, Attralus, GE Healthcare. Participated in the advisory board meeting for Janssen.
Dr. Ananthasubramaniam receives research funding to institution for study sponsored by Alnylam Pharmaceuticals.
Disclosure of Commercial
Support SCMR received funding to support this activity from the following organizations: None